COVID-19

SUMMARY OF THE COVID-19 VACCINATION PLAN

Sources: JFCCT as of 6 May 2021

  • Joint Standing Committee on Commerce, Industry, and Banking (JSCCIB) met the prime minister last week and give full support to the government.
  • Currently the vaccine procurement is at G2G level only.
  • The government has responsibility to purchase the highest quantity of vaccines possible
  • At least 100 million doses will be procured within this year.
  • 63 million doses are procured under G2G agreements. 61 million doses will be supplied by Astra Zeneca, which are made in Thailand. The certification is in the last phase of approval and will be released to the government in June. Another 2 million doses are from Sinovac. 37 million doses will be acquired from other manufacturer such as Pfizer, Johnson and Johnson, etc.
  • The aim is to vaccine 10 - 15 million people per month or 300,000 – 500,000 people per day, starting from June.
  • Board of Trade supports the government in terms of venues and distribution of the vaccine.
  • There will be no discrimination between Thais and foreigners.
  • The first priority group for vaccination is people living in the “Dark Red” zone (dangerous zone) with the most infections.
  • The second priority group are elderly people over the age of 60 and those with underlying illnesses.
  • The rest of the population will be vaccinated thereafter.
  • The different type of vaccine will be used to suit the safety of the appropriate age groups.
  • 3 million doses are reserved for the foreign community incl. foreign workers.
  • The foreign community may receive the vaccine in third or fourth quarter of 2021, but those with Thai spouses may receive the vaccination earlier.
  • The request to prioritize foreign investor/business is sent to BOI. JFCCT awaits feedback.
  • In May, all the medical staffs will be vaccinated.
  • Alternatively, there are attempts from private hospitals to purchase vaccines from Moderna and Sinopharm through FDA.
  • The FDA approved vaccines are Astra Zeneca, Sinovac and Johnson & Johnson.
  • The vaccines under FDA approval process are Moderna, Covaxin, Sputnik V and Pfizer BioNTech
  • Chulalongkorn University and Mahidol University are developing local vaccines, expected to be released early next year. These vaccines are now undergoing the second stage of trials.

News on the same theme

No news available.

Events on the same theme

Networking  • …

The VIRTUAL Event

Khon Kaen Business Forum

Two-day of business forum to detect business opportunities and build a strong link with key decision makers in Khon Kaen

Share this page Share on FacebookShare on TwitterShare on Linkedin
Close

Are you an FTCC Member?